Step 2/3

Contrast Media Injectors

Last updated on January 17, 2024
Company Product
ACIST Medical Systems, Inc. CVi Contrast Delivery System
Bayer HealthCare Medrad Stellant FLEX CT Injection System
Bayer HealthCare Medrad MRXperion MR Injection System
Bayer HealthCare Medrad Mark 7 Arterion Injection System
Bracco SpA EmpowerCTA+ Injector System
Bracco SpA CT Exprès 3D Contrast Media Delivery System
Bracco SpA EmpowerMR Injector System
GE HealthCare CTmotion
Guerbet OptiVantage Dual-Head CT Contrast Delivery System
Guerbet OptiStar Elite MR Contrast Delivery System
Guerbet Illumena Neo Contrast Delivery System
Guerbet OptiOne Single-head Contrast Delivery System
Nemoto North America, Inc. Press DUO Elite
Nemoto North America, Inc. DUAL SHOT alpha 7

Related Content

News | Contrast Media

August 17, 2023 — University of Missouri School of Medicine neurologist Adnan Qureshi, MD recently led a study that ...

Home August 17, 2023
Home
News | Contrast Media

July 3, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR) ...

Home July 03, 2023
Home
News | Contrast Media

May 11, 2021 — The American Institute of Ultrasound in Medicine (AIUM) and the American Society of Echocardiography (ASE ...

Home May 11, 2021
Home
Technology | Contrast Media

July 15, 2019 — The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic ...

Home July 15, 2019
Home
Videos | Contrast Media

Sharon Mulvagh, M.D., FASE, FACC, FRCPC, professor of medicine, division of cardiology, Dalhousie University, Halifax ...

Home June 28, 2019
Home
Feature | Contrast Media | Dave Fornell, Editor

Iodine-based contrast agents used in computed tomography (CT) and catheter-based angiography have been implicated as a ...

Home May 31, 2019
Home
News | Contrast Media

May 9, 2019 — Osprey Medical announced the launch of DyeMINISH, a global patient registry to evaluate the ongoing safety ...

Home May 09, 2019
Home
News | Contrast Media

November 30, 2018 — VigiLanz and Cincinnati Children’s Hospital Medical Center recently announced a collaboration that ...

Home November 30, 2018
Home
News | Contrast Media

In February 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Maryland, to explore ...

Home September 12, 2018
Home
News | Contrast Media

January 19, 2018 — Ligand Pharmaceuticals Inc. announced initiation of a program to develop contrast agents with reduced ...

Home January 19, 2018
Home
Subscribe Now